Furthermore, mangiferin was shown to protect against diabetes and dyslipidemia in diabetic, insulin resistant rats by improving insulin sensitivity, modulating lipid profile and reverting adipokine levels to normal [119]. The gene discussed is INS; the disease is metabolic syndrome.